Nexobrid Kit
Product Images NDC 69866-2002

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Nexobrid (NDC 69866-2002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vericel Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2g Sterile Lyophilized Powder And 20g Sterile Gel (Nexobrid 01)

NEXOBRID topical gel kit containing 8.8% anacaulase-bcdb. Kit net weight is 22 grams after mixing. Label includes storage instructions to refrigerate at 2°C to 8°C and warnings not to freeze. Manufactured by MediWound, Ltd and labeled by Vericel Corporation. Package contains a single-dose vial of powder and a single-dose jar of gel vehicle, with instructions for mixing and usage.*

FDA Label Image

5g Sterile Lyophilized Powder And 50g Sterile Gel (Nexobrid 02)

NEXOBRID kit packaging label shows the product name and active ingredient Anacaulase-BCDB. It specifies the dosage form as topical gel with 8.8% concentration and net weight of 55 grams after mixing. The label includes storage instructions, manufacturer details (MediWound, Ltd.), and the labeler Vericel Corporation. Additional text provides mixing and application directions along with ingredient information and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.